3NG
5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid
Find entries where: 3NG
is present as a standalone ligand in 18 entries
Chemical Component Summary | |
|---|---|
| Name | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid |
| Identifiers | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid |
| Formula | C19 H12 Cl N3 O2 |
| Molecular Weight | 349.77 |
| Type | NON-POLYMER |
| Isomeric SMILES | c1cc(cc(c1)Cl)Nc2c3ccncc3c4ccc(cc4n2)C(=O)O |
| InChI | InChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25) |
| InChIKey | MUOKSQABCJCOPU-UHFFFAOYSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 37 |
| Chiral Atom Count | 0 |
| Bond Count | 40 |
| Aromatic Bond Count | 22 |
Drug Info: DrugBank
| DrugBank ID | DB15408 |
|---|---|
| Name | Silmitasertib |
| Groups | investigational |
| Description | Silmitasertib is under investigation in clinical trial NCT03904862 (Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery). |
| Synonyms | Silmitasertib |
| Categories |
|
| CAS number | 1009820-21-6 |
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL1230165 |
| PubChem | 24748573 |
| ChEMBL | CHEMBL1230165 |
